NHE1/SLC9A1 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

NHE1/SLC9A1 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 17 amino acids near the center of human Nhe-1.

  Source: Synthetic

  (Accession #: P19634)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: SLC9A1
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76848.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for NHE1/SLC9A1 Antibody Blocking Peptide

• APNH
• APNH1
• APNHFLJ42224
• Na(+)/H(+) antiporter, amiloride-sensitive
• Na(+)/H(+) exchanger 1
• Na+/H+, amiloride sensitive)
• Na-Li countertransporter
• NHE1
• NHE-1
• NHE1Na+/H+ antiporter, amiloride-sensitive
• SLC9A1
• sodium/hydrogen exchanger 1
• solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter
• solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter
• solute carrier family 9 (sodium/hydrogen exchanger), member 1
• Solute carrier family 9 member 1

Background

The Na+/H+ antiporter (SLC9A1) is a ubiquitous membrane-bound enzyme involved in pH regulation of vertebrate cells. It is specifically inhibited by the diuretic drug amiloride and activated by a variety of signals including growth factors, mitogens, neurotransmitters, tumor promoters, and others (Mattei et al., 1988 [PubMed 2846238]).[supplied by OMIM]

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: SLC9A1